ONCY - Oncolytics Biotech Inc

Momentum: Bearish

Recent News

Oncolytics Biotech ( ONCY ) Loses -9.34% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks Commentary • 6 months, 1 week ago • score: 0.14

Oncolytics Biotech (ONCY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Bullish

Oncolytics Biotech ( ONCY ) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Commentary • 7 months, 1 week ago • score: 0.31

Oncolytics Biotech (ONCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. The company is headquartered in Calgary, Canada.

52W High

$1.53

52W Low

$0.33

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.19

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-1.79

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

24.31

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

3.61%

Institutions (25–75% balanced)

1.68%

Shares Outstanding

101,246,000

Float

98,776,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-0.27

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-2.49%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.1004

0.1002

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025